INOX trial : question period
The International Nocturnal Oxygen (INOX) trial is to determine, in patients with COPD not qualifying for LTOT but who present significant nocturnal arterial oxygen desaturation, whether nocturnal oxygen provided for a period of 3 years decreases mortality or delay the prescription of LTOT.
Date:
27 January 2021, 12:45
Venue:
This seminar will be held as a webinar. Please email samantha.thulborn@ndm.ox.ac.uk for the link to the event.
Speaker:
Professor Yves Lacasse (University of Laval)
Organising department:
NDM Experimental Medicine
Organiser:
Professor Ian Pavord (University of Oxford)
Organiser contact email address:
samantha.thulborn@ndm.ox.ac.uk
Host:
Professor Ian Pavord (University of Oxford)
Part of:
Respiratory Medicine BRC themed seminar series
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Samantha Thulborn
